Literature DB >> 326116

Epidemic diarrhea at Crater Lake from enterotoxigenic Escherichia coli. A large waterborne outbreak.

M L Rosenberg, J P Koplan, I K Wachsmuth, J G Wells, E J Gangarosa, R L Guerrant, D A Sack.   

Abstract

In June and July 1975, Gastrointestinal illness occurred in more than 200 staff members and 2000 visitors to an American national park. In was characterized by prolonged diarrhea, cramps, nausea, and vomiting, lasted a median duration of 8 days, and was significantly associated with consumption of park water (P less than 0.001), which had been contaminated by raw sewage. Enterotoxigenic Escherichia coli serotype 06:K15:H16 was isolated from 20 of 49 ill park residents and from the park's water supply, but not from 71 residents who had never been ill or had been well for at least 4 days. No other bacterial, viral, or parasitic pathogens were isolated from ill or well persons. This outbreak is the first waterborne epidemic of diarrheal illness shown to be due to enterotoxigenic. E. coli, and this study documents one mode of transmission of this pathogen. This investigation also suggests the relative insensitivity of current methods for identifying persons infected with this organism, either by the culturing of randomly selected isolates or by measuring serologic responses.

Entities:  

Mesh:

Year:  1977        PMID: 326116     DOI: 10.7326/0003-4819-86-6-714

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  51 in total

1.  Lack of virulence factors in Escherichia coli strains of enteropathogenic serogroups isolated from water.

Authors:  S R Valentini; T A Gomes; D P Falcão
Journal:  Appl Environ Microbiol       Date:  1992-01       Impact factor: 4.792

2.  Development of an immunomagnetic bead-immunoliposome fluorescence assay for rapid detection of Escherichia coli O157:H7 in aqueous samples and comparison of the assay with a standard microbiological method.

Authors:  Thomas R DeCory; Richard A Durst; Scott J Zimmerman; Linda A Garringer; Gary Paluca; Heleen H DeCory; Richard A Montagna
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

Review 3.  Treatment of traveller's diarrhoea. Economic aspects.

Authors:  M A Thomson; I W Booth
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

4.  Heat stable enterotoxin produced by Escherichia coli in acute diarrhoea.

Authors:  A Guarino; M Alessio; L Tarallo; M Fontana; G Iacono; L Gobio Casali; S Guandalini
Journal:  Arch Dis Child       Date:  1989-06       Impact factor: 3.791

5.  Recovery, growth, and production of heat-stable enterotoxin by Escherichia coli after copper-induced injury.

Authors:  A Singh; G A McFeters
Journal:  Appl Environ Microbiol       Date:  1986-04       Impact factor: 4.792

6.  Binding of E. coli heat-stable enterotoxin to rat intestinal brush borders and to basolateral membranes.

Authors:  A Guarino; M B Cohen; G Overmann; M R Thompson; R A Giannella
Journal:  Dig Dis Sci       Date:  1987-09       Impact factor: 3.199

7.  Use of a hemadsorption technique to evaluate the stability of the hemagglutination reaction of Escherichia coli cultures possessing human colonization factor antigens.

Authors:  D M Sedlock; H F Bartus; I Zajac; P Actor
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

8.  Assessment of in vivo revival, growth, and pathogenicity of Escherichia coli strains after copper- and chlorine-induced injury.

Authors:  A Singh; R Yeager; G A McFeters
Journal:  Appl Environ Microbiol       Date:  1986-10       Impact factor: 4.792

9.  Enterotoxigenic enteric bacteria in foods and outbreaks of food-borne diseases in Sweden.

Authors:  M L Danielsson; R Möllby; H Brag; N Hansson; P Jonsson; E Olsson; T Wadström
Journal:  J Hyg (Lond)       Date:  1979-08

10.  Enterotoxin-producing bacteria stools from Swedish United Nations soldiers in Cyprus.

Authors:  E Bäck; M Jonsson; T Wadström
Journal:  Infection       Date:  1978       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.